CClinicalTrials.gg
Status unknownNCT01940783ABMS1Updated Sep 12, 2013

Assessment of the AB HiFocusTM Mid Scala Electrode Movement Using Cone Beam Imaging Following Cochlea Implantation

An interventional study of Cone Beam Computed Tomography (CBCT) and Magnetic Resonance Imaging (MRI) in Cochlear Implantation and Cone-Beam Computed Tomography, sponsored by Maastricht University Medical Center. Status unknown at 1 site in Netherlands. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2013-09-12.

Sponsored by Maastricht University Medical Center · Not applicable, Interventional, and Diagnostic

The sponsor has not verified this record recently (last verified Sep 2013), so the status shown — last known as Recruiting — may be out of date.
Phase
Not applicable
Study type
Interventional
Enrollment
14
Allocation
Not applicable
Ages
18 Years and older
Sex
All
01

Study summary

One of the contributing factors to the variability in outcomes amongst Cochlear Implant (CI) recipients was reported to be the placement of the electrode array in the scala tympani. It seems that the correct placement of the electrode initially into the scala tympani and subsequent avoidance of dislocation into the scala vestibuli as the insertion progresses, is a key factor in achieving good speech perception outcomes. Another important aspect related to the performance is the achievement of consistent electrical coverage with the electrode. Data reported for electrodes of different manufacturers give depths ranging from 240 - 600 degrees showing the considerable variation across subjects. The HiFocus mid scala electrode was developed to cover one and a quarter turn and with the pre-curved design to be less susceptible to variations in individual cochlea dimensions and insertion techniques. A further mechanical feature of the pre-curved design is the avoidance of forces against the cochlear lateral wall and associated lower susceptibility of the electrode for moving out of the cochlea following insertion. Recently, a cone beam CT (CBCT) technique is being explored in the field of ENT with the potential to overcome some of the issues associated with the conventional CT techniques such as scattering, radiation and low isometric resolution. Images with comparable details to those of e.g. micro CTs are possible with much lower radiation dose. Modern imaging software i.e. 3D Slicer (www.slicer.org) may be used for 3D reconstruction, post processing and Brainsfit for registration. Registration is the alignment of two scans in the same coordinate system. This enables the identification of differences between two images recorded at time x and y. Once accurately superimposed any difference between the two images may be identified with an accuracy of 0.2 mm. Using these methods, one can assess the stability and the position of the electrode in the cochlea.

Objective: The primary objectives of this study are to evaluate the feasibility of using cone beam CT technique in combination with (high resolution) MRI to identify electrode movements following cochlear implant surgery and identify the inter-scalar position of the HFms electrode. The secondary objective is to quantify the average insertion depth and variations of the HFms electrode

02

Conditions studied

  • Cochlear Implantation
  • Cone-Beam Computed Tomography
03

In context

Lead sponsor

Maastricht University Medical Center is the lead sponsor of 835 studies on the registry; 122 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years and older
Sexes eligible
All
Accepts healthy volunteers
No

Inclusion criteria

  • Adults 18y or older meeting the conventional Dutch CI criteria
  • The patient will receives the HiFocus Mid Scala electrode
  • No cochlear or neural abnormalities that could compromise the placement of the electrode as assessed by the CI surgeon

Exclusion criteria

Exclusion Criteria:

  • Physical or non-physical contraindications for MRI or CT imaging
  • No additional disabilities that may prevent active participation and testing as per protocol
05

Study design

Phase
Not applicable
Primary purpose
Diagnostic
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrollment
14 participants (estimated)

Study arms

  • Other
    Intervention

    All participants in the study will receive one pre-operative MRI, prior to cochlear implantation, and two cone-beam computed tomography scans, after cochlear implantation

    Radiation: Cone Beam Computed Tomography (CBCT) · Device: Magnetic Resonance Imaging (MRI)

Interventions

  • RadiationCone Beam Computed Tomography (CBCT)

    Two postoperative CBCT scans, the first one on the day after cochlear implantation and the second after 3 months.

  • DeviceMagnetic Resonance Imaging (MRI)

    One pre-operative (before cochlear implantation) MRI scan of the cochlea.

06

What researchers measure

Primary outcomes

  1. movement of the electrode post-operatively in millimetres

    Time frame: 3 months

07

Study locations

1 of 1 sites recruiting
  • Maastricht University Medical Center
    Maastricht, Limburg 6202 AZ, Netherlands
    • Marc van Hoof, MD · Contact · marc.hoofvan@mumc.nl · +31433876543
    • Guido Dees, MD MSc · Contact · guido.dees@mumc.nl · +31433876543
    • Marc van Hoof, MD · Principal investigator
    • Guido Dees, MD MSc · Sub investigator
    Recruiting
08

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Sep 12, 2013, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
09

Registry details

Key details

Study ID
NCT01940783
Lead sponsor
Maastricht University Medical Center
Collaborators
Advanced Bionics
Responsible party
Guido Dees (MD, MSc, Maastricht University Medical Center) — Principal investigator
First posted
Sep 12, 2013
Start date
Sep 2013
Primary completion
Sep 2014 (estimated)
Completion
Sep 2014 (estimated)
Last update
Sep 12, 2013

Study contacts

Marc van Hoof, MD
Contact
marc.hoofvan@mumc.nl
+31433876543
Guido Dees, MD, MSc
Contact
guido.dees@mumc.nl
+31433876543
Robert Stokroos, MD PhD
principal investigator · Maastricht University Medical Center

Oversight

Data monitoring committee
Yes
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is status unknown, as verified in Sep 2013. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion